The opening of markets in the US shows a slowdown in the 2-day cycle of rallies, despite the positive announcement from Pfizer and BioNTech, which reported the efficacy of their Omicron variant vaccines.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appThe US30 index is slowing down its recent huge rallies and is stopped between the 78.6 and 61.8 Fibo retracements. If the supply side manages to drop the quotes below the 61.8 retracement resistance, it will be possible to accelerate the downward movement to the area of yesterday's closing price. The key for the bulls is the breakout above the level of 35 900 points, which will give a chance to test the zones near the highest levels of all time. Source: xStation 5
Market News:
Pfizer (PFE.US) and BioNTech (BNTX.US) announced that studies have shown that three doses of their Covid-19 vaccine can neutralize the Omicron variant, while two doses still provide protection. Pfizer and BioNTech also said they will continue to develop omicron-specific vaccines.
Pfizer (PFE.US) shares opened the day's trading with a bullish gap, following news of the medical giant's vaccine efficacy. The stock price has defended support near the psychological barrier of $50 per share during yesterday's session. If the bulls maintain their dominance, a renewed attempt to enter the ATH zones could be possible. Source: xStation 5
Roku (ROKU.US) signed a long-term agreement with Google (GOOGL.US) that will leave YouTube and YouTube TV on the company's streaming platform. Google has previously threatened to take its products off the Roku platform.
Meta Platforms (FB.US), formerly known as Facebook, has announced that it will fully open all of its US offices from 31 January 2022. Employees will have between three and five months to "get back behind their desks".
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
